Modified chitosan-based nanoadjuvants enhance immunogenicity of protein antigens after mucosal vaccination.


SINANI G., Sessevmez M., GÖK M. K., ÖZGÜMÜŞ S., ALPAR H., Cevher E.

International journal of pharmaceutics, vol.569, pp.118592, 2019 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 569
  • Publication Date: 2019
  • Doi Number: 10.1016/j.ijpharm.2019.118592
  • Journal Name: International journal of pharmaceutics
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.118592
  • Keywords: Nanoparticles, Nasal delivery, Mucosal vaccination, Chitosan, Antibody, Cytokine, N-TRIMETHYL CHITOSAN, PULLULAN COMPOSITE NANOPARTICLES, IN-VITRO, NASAL DELIVERY, INTRANASAL DELIVERY, MUCOADHESIVE PROPERTIES, ANTIBODY-RESPONSE, GEL FORMULATIONS, DENDRITIC CELLS, SURFACE-CHARGE
  • Istanbul University Affiliated: Yes